Intervenants

During this webcast, we will review the overall areas of focus identified by the SEC staff for public companies, the disclosure issues that members of the SEC staff have highlighted as important for upcoming annual reports on Form 10-K and Form 20-F, and discuss the particular hot button issues for life sciences companies. Among other things, we will discuss:

  • SEC comment trends;
  • A review of SEC proposed amendments to Regulation S-K disclosure requirements;
  • Early Experiences with CAMs;
  • Revenue recognition comments relating to licensing and collaboration agreements;
  • Other SEC disclosure areas of focus

 



CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.